UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042194
Receipt number R000048028
Scientific Title The effect of the test substance on oral function, stress and immunity.
Date of disclosure of the study information 2020/10/22
Last modified on 2021/04/21 12:59:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of the test substance on oral function, stress and immunity.

Acronym

The effect of the test substance on oral function, stress and immunity.

Scientific Title

The effect of the test substance on oral function, stress and immunity.

Scientific Title:Acronym

The effect of the test substance on oral function, stress and immunity.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the effects of using the test substance to improve oral function, increase blood flow, improve skin quality, reduce stress, improve sleep, and improve immunity.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Confirmation of salivary quantity by Saxon test,
Pittsburgh Sleep Quality Index,
Secretory IgA.

Key secondary outcomes

Body temperature when wake up, Body temperature 1hr after bath, Body temperature before going to bed, With or without subjective symptom of chill, Blood flow, Skin moisture level, QOL Common Questionnaire.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Taking bath once a day as more than 15 min submerged to the shoulder level in bathtub filled with hot water (below 41 degrees centigrade) which dissolved 4 tablets of test substance. Continue taking bath everyday for 9 days as similar way.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

70 years-old >

Gender

Female

Key inclusion criteria

1) Female aged between 40 and 70 years old at when they were informed consent.
2) Must be able to bathe once a day during the test period.
3) A person who has received a full explanation of the purpose and content of the test and who understands the test and is able to obtain his or her written consent.

Key exclusion criteria

1)Subjects who are treated by medicine continuously.
2)Subjects who regularly take functional food and/or health food which is expected to improve chilliness, blood-flow or body temperature, skin quality, stress, sleep and immunity.
3)Subjects who have previous and/or current medical history of serious disease in heart, liver, kidney, digestive organ, skin and central nervous system.
4)Subjects who have disease making unconsciousness at seizure, like arrhythmia, anemia, sleep apnea syndrome, epilepsy or diabetes.And subjects who are previous diagnosed as the same disease.
5)Pregnant or possibly pregnant women, or lactating women.
6)Subjects who have extremely irregular food habits. Subjects who have irregular life cycle because midnight-work or shift-work.
7)Subjects who are participating in the other clinical tests. Subjects who participated within 4 weeks prior to the current study and/or who plan to participate in the other clinical tests.
8)Subjects who have had skin symptoms such as itching and eczema, using bath additives in the past.
9)Subjects who have been judged as unsuitable for the study by the principal investigator or sub-investigator.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Ichiro
Middle name
Last name Saito

Organization

Tsurumi University

Division name

Department of Pathology, School of Dental Medicine

Zip code

230-8501

Address

2-1-3,Tsurumi,Tsurumi-ku,Yokohama,Kanagawa,230-0063,Japan

TEL

045-580-8362

Email

saito-i@tsurumi-u.ac.jp


Public contact

Name of contact person

1st name Mie
Middle name
Last name Kaneko

Organization

Chiyoda Oralhealth Care Clinic

Division name

None.

Zip code

101-0061

Address

Suidobashi Nishiguchi Kaikan 3F, 2-20-7 Kanda-Misaki-cho, Chiyoda-ku, Tokyo, 101-0061, Japan

TEL

03-3288-8801

Homepage URL


Email

info@cocc.jp


Sponsor or person

Institute

Chiyoda Oralhealth Care Clinic

Institute

Department

Personal name



Funding Source

Organization

HOT ALBUM Tansansen Tablet, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Sanwauchikanda Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, Japan

Tel

03-5297-5548

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

4

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 09 Month 18 Day

Date of IRB

2020 Year 09 Month 18 Day

Anticipated trial start date

2020 Year 10 Month 15 Day

Last follow-up date

2020 Year 12 Month 27 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 10 Month 21 Day

Last modified on

2021 Year 04 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048028


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name